Tag Archives: LRCX

Top 10 Bank Stocks To Invest In Right Now

 Today, I (Porter) am going to introduce a new financial term…   I've been thinking about this a while… it's a term that describes the modern economy's fondness for central banks, paper money, huge debts, and financial bubbles. I call it the "Escher Economy."   I hope you'll read carefully. Remember… there's no such thing as teaching, only learning.    About five years ago, investors around the world began piling into Japanese stocks…   It was a surprising move.   Japanese stocks have been a virtual graveyard for capital since the late 1980s. That's when Japan's big real estate and investment bubble collapsed. The Japanese "Dow" – the Nikkei 225 Index – briefly soared from around 10,000 to more than 40,000… and then collapsed.

Top 10 Bank Stocks To Invest In Right Now: Monotype Imaging Holdings Inc.(TYPE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Monotype Imaging Holdings Inc. (NASDAQ: TYPE) were down around 12 percent to $20.90 after the company posted downbeat quarterly earnings.

  • [By Lisa Levin]

    Wednesday afternoon, the non-cyclical consumer goods & services shares surged 0.61 percent. Meanwhile, top gainers in the sector included Monotype Imaging Holdings Inc. (NASDAQ: TYPE), up 9 percent, and Semiconductor Manufacturing Int'l (ADR) (NYSE: SMI), up 6 percent.

Top 10 Bank Stocks To Invest In Right Now: CBOE Holdings Inc.(CBOE)

Advisors’ Opinion:

  • [By David Zeiler]

    Bats Global Markets was acquired on Feb. 28 by the Chicago Board Options Exchange (Nasdaq: CBOE).

    But the Bats BZX Exchange has had a bigger role than just serving as the place where the Winklevoss ETF will be listed…

  • [By David Zeiler]

    Bitcoin futures trading started at the CBOE Global Markets Inc. (Nasdaq: CBOE) on Dec. 10 and on the much larger CME Group Inc. (Nasdaq: CME) on Dec. 18. Nasdaq Inc. (Nasdaq: NDAQ) plans to begin trading Bitcoin futures in the first half of next year.

  • [By CNNMoney Staff]

    Stocks continued to rally despite the fact that options trading was temporarily halted Monday afternoon at exchanges run by CBOE Holdings (CBOE), Nasdaq OMX (NDAQ), BATS Global Markets and Miami International Holdings due to issues at the Options Price Reporting Authority (OPRA), which provides trading data and price quotes.

  • [By Wayne Duggan]

    Wall Street has been watching bitcoin this week, with the price up another 39.8 percent to above $16,000 ahead of the highly anticipated launch of bitcoin futures trading by Cboe Global Markets Inc (NASDAQ: CBOE) starting Sunday. Bitcoin has been around for years, but bitcoin futures trading will make trading a breeze for average retail investors for the first time.

  • [By Saumya Vaishampayan
    var popups = $(“.socialByline .popC”); ]

    Those who dabble in derivatives tied to the CBOE (CBOE) Volatility Index are placing bets that pay out if the stock market keeps swinging, and especially if it drops.

Top 10 Bank Stocks To Invest In Right Now: Forward Pharma A/S(FWP)

Advisors’ Opinion:

  • [By Jim Robertson]

    Last Friday, our Under the Radar Moversnewsletter suggested going long on small cap clinical-stage biopharmaceutical stock Forward Pharma A/S (NASDAQ: FWP):

  • [By George Budwell]

    Shares of theDanish drugmaker Forward Pharma A/S (NASDAQ:FWP) gained 48.2% yesterday as the result of a settlement and licensing deal with Biogen (NASDAQ:BIIB)involving an ongoing patent dispute over the multiple sclerosis drug Tecfidera. Per the terms of the deal, Biogen will fork overa non-refundable$1.25 billion licensing fee, and possibly pay 10% to 20% royalties on Tecfidera’snet sales to Forward starting in 2021.

Top 10 Bank Stocks To Invest In Right Now: Internet Gold Golden Lines Ltd.(IGLD)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, telecommunications services shares fell by 0.43 percent. Meanwhile, top losers in the sector included Internet Gold Golden Lines Ltd (NASDAQ: IGLD), down 10 percent, and China Unicom (Hong Kong) Limited (ADR) (NYSE: CHU), down 3 percent.

Top 10 Bank Stocks To Invest In Right Now: Lam Research Corporation(LRCX)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Wednesday was a mixed day for the stock market, as the Dow Jones Industrials dropped by triple digits but other major benchmarks fared much better. Crude oil prices fell nearly $2 per barrel to $50.50, and that hurt energy companies, along with a poor earnings report from technology giant IBM. Yet the broader market held up better, and the Nasdaq Composite actually gained ground. In particular, some good news from a few individual companies helped hold the markets up, and CalAmp (NASDAQ:CAMP), Lithia Motors (NYSE:LAD), and Lam Research (NASDAQ:LRCX) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

  • [By WWW.THESTREET.COM]

    The same case is made for Action Alerts PLUS holding Alphabet (GOOGL) and for Lam Research (LRCX) and Broadcom (AVGO) and Growth Seeker holding Amazon (AMZN) –and a host of other high-growth companies.

  • [By Ben Levisohn]

    Lam Research (LRCX) soared to the top of the S&P 500 today after beating earnings forecasts and raising its fourth-quarter guidance.

    Getty Images

    Lam Researchgained 6.9% to $136.17 today, while the S&P 500 declined 0.2% to 2,338.17.

    Credit Suisse analysts Farhan Ahmad and John Pitzer and argues that Lam Research’s “new trough is higher than [its] old peak.” They explain:

    We expect that bears will continue to argue that CY17 is a “Peak” year; however we think that investors are missing that it now costs >2x more to get incremental bit growth than three years ago. It is noteworthy that despite ~$17bn of memory WFE in 2016 both NAND and DRAM markets went from oversupply to undersupply – implying that new trough for memory investments is even higher than old peak (2010 memory peak had WFE of $12.6bn). We view Semi Growth, rising capital intensity, and growing China CapEx as secular multiyear themes, which could continue to provide growth in coming years. In addition, in case of tax reform there could be potential to return >$50 per share to shareholders by 2020…Increase TP to $160 (from $143), based on 12x of CY18 EPS plus net cash adj for taxes.

    Lam Research’s market capitalization rose to $22.2 billion today from $20.8 billion yesterday.

  • [By WWW.MONEYSHOW.COM]

    Lam Research (LRCX) has consistently outgrown the overall semiconductor-equipment market due to its high exposure to 3D NAND flash memory.

    Demand for wafer-fabrication equipment is notoriously volatile. However, over the last 90 days, the consensus profit estimate for this year jumped 17%, with 95% of analysts raising their targets.

Top 10 Bank Stocks To Invest In Right Now: VistaGen Therapeutics, Inc. (VTGN)

Advisors’ Opinion:

  • [By Money Morning News Team]

    For instance, VistaGen Therapeutics Inc. (Nasdaq: VTGN) shot up from $0.92 to $2.55 on Dec. 6. Since then, the stock pulled back to $1.02. Investors who bought at $2.55 are sitting on a 60% loss today (Dec. 18).

  • [By William Romov]

    VistaGen Therapeutics Inc. (Nasdaq: VTGN) is among the top penny stocks to watch this week after climbing 135% in just three trading sessions last week.

  • [By SEEKINGALPHA.COM]

    Four ideas turned up in this screen that might be of interest (prices as of February 9th close):

    Heron Therapeutics (NASDAQ:HRTX) by ONeil Trader – published February 3rd, 2017, $525M Market cap, down ~2% since publication, author’s price target offers 130% upside. HRTX isn’t a generic drug provider, but its CINV franchise vs. the growth of a new drug gives it a similar sort of profile, and arguably a favorable risk/reward; commenters were mostly positive on the thesis. VistaGen Therapeutics (OTC:VTGN) by Logical Assessment – published July 29, 2016, $24M market cap, down 16% since publication, author’s price target offers 100%+ upside. This is obviously deeper into the speculative pile, but if the author’s thesis holds about VistaGen’s unique angle in the antidepressant drug space, comparable deals suggest good upside. (Of course, it’s always dangerous to rely solely on comparables). Dr. Reddy’s Laboratories (NYSE:RDY) by Buddy Lyons – published July 5, 2016, $7.6B market cap, down ~13% since publication, author’s price target offers just shy of 100% upside. Dr. Reddy’s is a more obvious comparable to TEVA, with a generics business but also a manufacturing business and a proprietary products branch. The company bought a divestiture package of drugs from TEVA as part of the Allergan/Actavis deal. A big overhang was an FDA warning letter; the FDA is due to reinspect facilities this month or next, which could resolve that one way or another. Lannett (NYSEMKT:LCI) by Lateral Capital Management – published May 27, 2016, $750M market cap, down ~9% since publication, author’s price target offers 75% upside. LCI’s trading had been 90% correlated with Valeant, but Lateral Capital Management argues that the correlation is unjustified. The article does a deep dive into the company’s valuation and credit risk, and was well received at the time, even if the market hasn’t agreed…yet.

    I also checked to see if there are any ideas starting to play out on the short si

Top 10 Bank Stocks To Invest In Right Now: Grow Solutions Holdings, Inc. (GRSO)

Advisors’ Opinion:

  • [By Javier Hasse]

    Grow Solutions Holdings Inc (OTC: GRSO) acquired Keys Organic and Hydroponic Supply.

    "What we are starting to see here is aggregation in the highly-fragmented hydroponic and grow supply industry. Most of these stores, including Keys Organic and Hydroponic Supply, are typically local or regional — This results in a very fragmented market."
    "We saw this [aggregation] happen with grocery stores, the finance industry, auto dealerships — Bigger names come in. So, instead of Bob's Ford Motor Company (NYSE: F) Dealership or Fred'sGeneral Motors Company (NYSE: GM) outlet, you'll get companies likeAutoNation, Inc. (NYSE: AN) come in, put them under a single brand, consolidate HR and other expenses to develop economies of scale and really help additional bottom line."
    “Another way to look at it is, there's coffee shops all around the world, but there's also Starbucks Corporation (NASDAQ: SBUX), which started locally […] and developed really organically. But, they could just buy the local coffee shop, redesign it to the Starbucks brand, put their name on it… Now they have the distribution network, the backing of Starbucks, Starbucks will take care of their HR, their payroll — It's a more synergistic approach and a really value-add if they can consolidate any level of scale.”

    Elev8 Brands Inc (OTC: VATE) acquired O2 Breathe, LLC, a company supplying portable oxygen bars and aromatherapy inhalers.

Top 10 Bank Stocks To Invest In Right Now: Atkore International Group Inc. (ATKR)

Advisors’ Opinion:

  • [By Spencer Israel]

    3. Atkor International Group Inc (NYSE: ATKR) – Five of the six analyst ratings on the manufacturing holding company have been bullish. With the stock showing very strong technical support at $16, and currently trading at $16.68, Stockal's confidence meter is at 90%. 

  • [By Ben Levisohn]

    Flexing the barbell strategy to balance Safe Havens with more cyclical exposures. In our view, industrials investors should be positioning their portfolio with a barbell strategy, with half of the exposure in Safe Havens like General Electric, Xylem (XYL), Danaher, Honeywell International, Roper Technologies (ROP), and AMETEK (AME), and the other half selectively in the cyclical names that are better positioned today, such as Pentair, HD Supply Holdings (HDS),Actuant (ATU), Atkore International Group (ATKR), Ingersoll-Rand, and Eaton (ETN). We still believe risk-reward is mostly balanced and that the macro will remain choppy into 2017, supporting a positioning in the defensive names. But if investor sentiment improves on not-worse news and earnings results, the more cyclical names could fare better.

Top 10 Bank Stocks To Invest In Right Now: Insmed, Inc.(INSM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Insmed Incorporated (NASDAQ: INSM) shares shot up 113 percent to $26.15 following the announcement of positive top-line results from its Phase 3 Convert study of ALIS in adult patients with treatment-refractory nontuberculous Mycobacterial (NTM) lung disease..

Top 10 Bank Stocks To Invest In Right Now: Omnicom Group Inc.(OMC)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    We reprise five of last year’s components: Boeing (BA), CVS Health (CVS), International Business Machines (IBM), Omnicom Group (OMC) and Texas Instruments (TXN), which means they obviously are buys.

Hot Value Stocks To Own For 2018

Richmond, VA, based Investment company Blue Edge Capital, LLC buys Vanguard FTSEEuropean, iShares Global Infrastructure ETF, Altria Group Inc, The Home Depot Inc, Lowe’s Inc, Goldman Sachs Group Inc, iShares S&P 500 Growth, Philip Morris International Inc, iShares S&P 500 Value, sells SPDR Select Sector Fund – Energy Select Sector, Gilead Sciences Inc during the 3-months ended 2017-03-31, according to the most recent filings of the investment company, Blue Edge Capital, LLC. As of 2017-03-31, Blue Edge Capital, LLC owns 73 stocks with a total value of $191 million. These are the details of the buys and sells.

New Purchases: IGF, LOW, GS, IVW, PM, Added Positions: VGK, VWO, MO, VTV, VUG, HD, VPL, VIG, IJJ, IJK, Reduced Positions: LQD, IEI, MBB, PFF, HYG, TIP, CAT, DIS, SHW, Sold Out: XLE, GILD,

For the details of Blue Edge Capital, LLC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Blue+Edge+Capital%2C+LLC

These are the top 5 holdings of Blue Edge Capital, LLCVanguard Value ETF – DNQ (VTV) – 186,478 shares, 9.3% of the total portfolio. Shares added by 4.97%Vanguard Growth ETF – DNQ (VUG) – 134,248 shares, 8.54% of the total portfolio. Shares added by 4.91%Vanguard FTSEEuropean (VGK) – 288,351 shares, 7.77% of the total portfolio. Shares added by 22.86%Vanguard FTSE Emerging Markets (VWO) – 284,604 shares, 5.91% of the total portfolio. Shares added by 18.75%Vanguard FTSE Pacific (VPL) – 158,101 shares, 5.23% of the total portfolio. Shares added by 4.61%New Purchase: iShares Global Infrastructure ETF (IGF)

Blue Edge Capital, LLC initiated holdings in iShares Global Infrastructure ETF. The purchase prices were between $39.04 and $42.32, with an estimated average price of $40.45. The stock is now traded at around $43.76. The impact to the portfolio due to this purchase was 0.59%. The holdings were 26,699 shares as of 2017-03-31.

Hot Value Stocks To Own For 2018: Luxoft Holding, Inc.(LXFT)

Advisors’ Opinion:

  • [By Steve Symington]

    Luxoft Holding(NYSE:LXFT)announced strong fiscal fourth-quarter results on Monday, after the market closed. Similar to its modest post-earnings drop in February, shares of the software development specialist fell 3.6% on Tuesday as investors absorbed the news.

Hot Value Stocks To Own For 2018: Cooper Tire & Rubber Company(CTB)

Advisors’ Opinion:

  • [By Matt Hogan]

    Finbox.io fair value data (as of January 4) shows that there are only five US manufacturing stocks that have 25% or more margin of safety: Vera Bradley, Inc. (NASDAQ: VRA), Cooper Tire & Rubber Co (NYSE: CTB), Farmer Brothers Co. (NASDAQ: FARM), Allergan plc Ordinary Shares (NYSE: AGN) and Motorcar Parts of America, Inc. (NASDAQ: MPAA).

Hot Value Stocks To Own For 2018: Gap, Inc. (The)(GPS)

Advisors’ Opinion:

  • [By Douglas A. McIntyre]

    One of the notable things about the mall is the number of troubled retailers it houses. Long term, this may be bad for the mall’s finances. Macy’s, Abercrombie & Fitch Co. (NYSE: ANF), GameStop Corp. (NYSE: GME) and Gap Inc. (NYSE: GPS) have locations. However, Mall of America has buttressed its tenant list with scores of restaurants and with retailers like Apple Inc. (NASDAQ: AAPL), Microsoft Corp. (NASDAQ: MSFT) and T-Mobile US Inc. (NASDAQ: TMUS), which have very well-financed parents.

  • [By Ben Levisohn]

    L Brands surged 11% to $47.85 today, while the S&P 500 rose 0.2% to2,357.49. And while L Brands was the best performer, retailers made up half of the 10 best performing stocks in the benchmark today: Nordstrom (JWN) advanced 2.9% to $44.71, Gap (GPS) jumped 5.1% to $24.06, Kohl’s (KSS) climbed 5.6% to $39.60, andBed Bath & Beyond (BBBY), which reported earnings last night, gained 3.4% to $39.08.

  • [By Peter Graham]

    A long term performance chart shows Abercrombie & Fitch Co underperforming and giving a negative performance while mid capUrban Outfitters, Inc (NASDAQ: URBN)and large capThe Gap Inc (NYSE: GPS) are at least in positive territory and have been trending back up:

Hot Value Stocks To Own For 2018: Lam Research Corporation(LRCX)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Lam Research (LRCX) has consistently outgrown the overall semiconductor-equipment market due to its high exposure to 3D NAND flash memory.

    Demand for wafer-fabrication equipment is notoriously volatile. However, over the last 90 days, the consensus profit estimate for this year jumped 17%, with 95% of analysts raising their targets.

  • [By Dan Caplinger]

    Wednesday was a mixed day for the stock market, as the Dow Jones Industrials dropped by triple digits but other major benchmarks fared much better. Crude oil prices fell nearly $2 per barrel to $50.50, and that hurt energy companies, along with a poor earnings report from technology giant IBM. Yet the broader market held up better, and the Nasdaq Composite actually gained ground. In particular, some good news from a few individual companies helped hold the markets up, and CalAmp (NASDAQ:CAMP), Lithia Motors (NYSE:LAD), and Lam Research (NASDAQ:LRCX) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

  • [By WWW.THESTREET.COM]

    The same case is made for Action Alerts PLUS holding Alphabet (GOOGL) and for Lam Research (LRCX) and Broadcom (AVGO) and Growth Seeker holding Amazon (AMZN) –and a host of other high-growth companies.

  • [By Ben Levisohn]

    Lam Research (LRCX) soared to the top of the S&P 500 today after beating earnings forecasts and raising its fourth-quarter guidance.

    Getty Images

    Lam Researchgained 6.9% to $136.17 today, while the S&P 500 declined 0.2% to 2,338.17.

    Credit Suisse analysts Farhan Ahmad and John Pitzer and argues that Lam Research’s “new trough is higher than [its] old peak.” They explain:

    We expect that bears will continue to argue that CY17 is a “Peak” year; however we think that investors are missing that it now costs >2x more to get incremental bit growth than three years ago. It is noteworthy that despite ~$17bn of memory WFE in 2016 both NAND and DRAM markets went from oversupply to undersupply – implying that new trough for memory investments is even higher than old peak (2010 memory peak had WFE of $12.6bn). We view Semi Growth, rising capital intensity, and growing China CapEx as secular multiyear themes, which could continue to provide growth in coming years. In addition, in case of tax reform there could be potential to return >$50 per share to shareholders by 2020…Increase TP to $160 (from $143), based on 12x of CY18 EPS plus net cash adj for taxes.

    Lam Research’s market capitalization rose to $22.2 billion today from $20.8 billion yesterday.

Hot Value Stocks To Own For 2018: Pilot Gold Inc (PLGTF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Wesdome Gold (OTC:WDOFF) is confirming the potential of its Kiena Deeps discovery with the latest batch of drill results from this venue. Itinerant Musings subscribers who joined us in this trade will be pleased. Treasury Metals (OTC:TSRMF) needs to find more underground ore to justify a construction decision of its Goliath gold project, and it’s doing just that as reported in the latest news release and explained in this article. NuLegacy Gold (OTCQX:NULGF) finally announced results from the twin hole of the Avocado discovery. A detailed discussion will be forthcoming for Itinerant Musings subscribers shortly. Pilot Gold (OTCPK:PLGTF) is making progress at its Goldstrike project in Utah. The latest set of results confirmed the Peg Leg and Covington targets as valid targets for further drilling. Arizona Mining (OTC:WLDVF) is countering controversy by releasing more drill results, and reporting the discovery of Taylor Deeps. The roller coaster continues.

Top 10 Heal Care Stocks To Buy For 2018

Stocks finished the week slightly higher this week–save for the Dow Jones Industrial Average–as election concerns, volatile oil prices, and a stronger dollar failed to waylay the market.

Getty Images

The S&P 500 rose 0.4% this week after finishing little changed at2,141.16 today, while the Dow Jones Industrial Average finished little changed this week after declining 16.64 points, or 0.1%, to 18,145.71 today. The Nasdaq Composite gained 0.8% this week after advancing 0.3% to 5,257.40 today.

It was a see-saw battle between the bulls and bears this week. The presidential debate did little to soothe fears of a November surprise; the strong dollar raised fears of earnings pressure for multinational companies, and oil failed to break out. Ultimately, the question about where stocks are headed next went unanswered. Citigroup’s Tobias Levkovich and team see the “balance to be tilted in favor of higher stock prices next year.” They explain why:

Top 10 Heal Care Stocks To Buy For 2018: Cedar Fair, L.P.(FUN)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Cramer was bearish on Hertz Global Holdings (HTZ) , General Motors (GM) , Pandora Media (P) , Cedar Fair (FUN) , Quotient Technology (QUOT) and Rite Aid (RAD) .

  • [By Peter Graham]

    A long term performance chart shows shares of SeaWorld Entertainment mostly underperforming since the IPO and largelymoving sideways for the past 2 1/2 years whileamusement park stocks Six Flags Entertainment Corp (NYSE: SIX) and Cedar Fair, L.P. (NYSE: FUN) have generally been steady performers for investors:

Top 10 Heal Care Stocks To Buy For 2018: Cognizant Technology Solutions Corporation(CTSH)

Advisors’ Opinion:

  • [By Lee Jackson]

    Cognizant Technology Solutions Corp. (NASDAQ: CTSH) is starting to show up as a stock to buy for many of the Wall Street firms we cover. The company was very bullish at the conference and cited a very solid demand environment that is expected to continue through next year. The Deutsche Bank target for the stock is placed at $92, while the consensus number is at $87.

  • [By Monica Gerson]

    Cognizant Technology Solutions Corp (NASDAQ: CTSH) is estimated to report its quarterly earnings at $0.79 per share on revenue of $3.23 billion.

    CIGNA Corporation (NYSE: CI) is projected to report its quarterly earnings at $2.15 per share on revenue of $10.00 billion.

  • [By Paul Ausick]

    Cognizant Technology Solutions Corp. (NASDAQ: CTSH) dropped more than 17% on Friday to post a new 52-week low of $45.44 after closing at $55.00 on Thursday. The stock’s 52-week high is $69.80. Volume was more than 10 times the daily average of around 4.2 million shares. The company’s president has been replaced as an investigation into possible corruption charges begins.

  • [By Lisa Levin]

    Cognizant Technology Solutions Corp (NASDAQ: CTSH) reported better-than-expected earnings for its first quarter, but issued a weak guidance for the current quarter.

  • [By WWW.THESTREET.COM]

    And Elliott could be pressuring two public companies to combine. One company that analysts contend could be interested in buying Advisory Board’s healthcare business, which represents about 80% of the company, is Cognizant Technology Solutions (CTSH) . The Teaneck, N.J.-based business has been under pressure in recent months by Elliott Management to take on more leverage to help fund research and M&A. 

  • [By Shanthi Rexaline]

    The industry — valued at over $150 billion and comprising companies such as Wipro Limited (ADR) (NYSE: WIT), Cognizant Technology Solutions Corp (NASDAQ: CTSH), Infosys Ltd ADR (NYSE: INFY) and Tata Consultancy Services — has thus far been competing effectively on certain unique selling propositions such as low-cost technology skills and high quality manpower.

Top 10 Heal Care Stocks To Buy For 2018: American Woodmark Corporation(AMWD)

Advisors’ Opinion:

  • [By Lisa Levin]

    American Woodmark Corporation (NASDAQ: AMWD) was down, falling around 13 percent to $70.39 as the company reported weaker-than-expected quarterly earnings.

  • [By Lisa Levin]

    American Woodmark Corporation (NASDAQ: AMWD) was down, falling around 17 percent to $66.88 as the company reported weaker-than-expected quarterly earnings.

Top 10 Heal Care Stocks To Buy For 2018: FXCM Inc.(FXCM)

Advisors’ Opinion:

  • [By Lisa Levin]

    FXCM Inc (NASDAQ: FXCM) shares dropped 53 percent to $3.24 after the company announced regulatory settlements with NFA and CFTC against its U.S. subsidiary, Forex Capital Markets LLC. Gain Capital Holdings Inc (NYSE: GCAP) agreed to acquire the client base of FXCM's U.S. operations after FXCM reported that it will be withdrawing from U.S. business.

Top 10 Heal Care Stocks To Buy For 2018: Textainer Group Holdings Limited(TGH)

Advisors’ Opinion:

  • [By Joseph Hogue]

    There is one particular shipping company of which investors are being especially fearful, to the point of hating it. I'm talking about Textainer Group Holdings (NYSE: TGH), a container leasing company with 2.6 million 20-foot equivalent containers, the largest fleet among its peers.

Top 10 Heal Care Stocks To Buy For 2018: Lam Research Corporation(LRCX)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Lam Research (LRCX) soared to the top of the S&P 500 today after beating earnings forecasts and raising its fourth-quarter guidance.

    Getty Images

    Lam Researchgained 6.9% to $136.17 today, while the S&P 500 declined 0.2% to 2,338.17.

    Credit Suisse analysts Farhan Ahmad and John Pitzer and argues that Lam Research’s “new trough is higher than [its] old peak.” They explain:

    We expect that bears will continue to argue that CY17 is a “Peak” year; however we think that investors are missing that it now costs >2x more to get incremental bit growth than three years ago. It is noteworthy that despite ~$17bn of memory WFE in 2016 both NAND and DRAM markets went from oversupply to undersupply – implying that new trough for memory investments is even higher than old peak (2010 memory peak had WFE of $12.6bn). We view Semi Growth, rising capital intensity, and growing China CapEx as secular multiyear themes, which could continue to provide growth in coming years. In addition, in case of tax reform there could be potential to return >$50 per share to shareholders by 2020…Increase TP to $160 (from $143), based on 12x of CY18 EPS plus net cash adj for taxes.

    Lam Research’s market capitalization rose to $22.2 billion today from $20.8 billion yesterday.

  • [By WWW.THESTREET.COM]

    The same case is made for Action Alerts PLUS holding Alphabet (GOOGL) and for Lam Research (LRCX) and Broadcom (AVGO) and Growth Seeker holding Amazon (AMZN) –and a host of other high-growth companies.

  • [By Dan Caplinger]

    Wednesday was a mixed day for the stock market, as the Dow Jones Industrials dropped by triple digits but other major benchmarks fared much better. Crude oil prices fell nearly $2 per barrel to $50.50, and that hurt energy companies, along with a poor earnings report from technology giant IBM. Yet the broader market held up better, and the Nasdaq Composite actually gained ground. In particular, some good news from a few individual companies helped hold the markets up, and CalAmp (NASDAQ:CAMP), Lithia Motors (NYSE:LAD), and Lam Research (NASDAQ:LRCX) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

Top 10 Heal Care Stocks To Buy For 2018: Catalyst Biosciences, Inc. (CBIO)

Advisors’ Opinion:

  • [By Ashley Moore]

    Here is a list of the top 10 best small-cap stocks based on price gains per share so far in 2017:

    Company (Ticker)Price per Share% Change AquaBounty Technologies Inc. (Nasdaq: AQB)$14.338,646.99%Rennova Health Inc. (Nasdaq: RNVA)$3.133,333.73%China Gengsheng Minerals Inc. (OTCMKTS: CHGS)$0.021,718.18%Sunshine Heart Inc. (Nasdaq: SSH)$3.851,071.43%CTI BioPharma Corp. (Nasdaq: CTIC)$4.30991.76%Catalyst Biosciences Inc. (Nasdaq: CBIO)$6.22853.85%TearLab Corp. (Nasdaq: TEAR)$4.20707.85%Pulmatrix Inc. (Nasdaq: PULM)$3.86566.10%Real Goods Solar Inc. (Nasdaq: RGSE)$1.43498.75%Calithera Biosciences Inc. (Nasdaq: CALA)$11.70281.54%

  • [By Lisa Levin]

    Shares of Catalyst Biosciences Inc (NASDAQ: CBIO) were down around 27 percent to $5.36. Catalyst Biosciences reported the pricing of $18 million offering of Class A units at $5 per unit

Top 10 Heal Care Stocks To Buy For 2018: BIG YELLOW GROUP PLC (BYLOF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The Big Yellow Group (OTC:BYLOF) recognized this opportunity back in 1998 when it was founded and has ever since been working towards bringing new supply of self-storage properties to the UK market. The strategy resulted in the following performance:

Top 10 Heal Care Stocks To Buy For 2018: Sociedad Quimica y Minera S.A.(SQM)

Advisors’ Opinion:

  • [By Beth McKenna]

    Most investors interested in gaining exposure to the lithium space should stick with investing in one or more of the large players listed on a major U.S. stock exchange:Albemarle Corporation(NYSE:ALB), FMC Corp. (NYSE:FMC), andSociedad Quimica y Minera de Chile(NYSE:SQM), or SQM. Smaller players are speculative to varying degrees, and most are unprofitable.

Top 10 Heal Care Stocks To Buy For 2018: ANSYS, Inc.(ANSS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Wednesday's regular session.

5 ‘Strong Buy’ Dividend Growth Stocks for 2018

What is the holy grail of dividend investing? Stocks in strong companies that pay out a high dividend yield. The yield can provide a steady source of income every quarter, which will hopefully increase over time. You can even reinvest the dividend back into the company to further bump up your holding. Plus, dividend growth stocks from financially healthy companies can also help you to hedge your risk against more volatile stocks.

So how we can pinpoint these elusive stocks? In this case, I used TipRanks’ innovative stock screener. The screener is a great way to find stocks that match your investing criteria and have significant support from the Street’s best analysts. Here I set the filter for stocks with a “positive,” “high” or “very high” dividend yield and a “strong buy” top analyst consensus rating.

These are the Street’s top analysts according to their success rate and average return. I left the other filters open e.g. sector, market cap, etc. From the list pulled up by the screener, I specifically searched for stocks with big dividend growth and strong potential rather than just the current yield rate.

A stock that pays a high dividend yield is ultimately disappointing in the long-run if the dividend shrinks rather than grows. And a bullish company with an impressive dividend growth rate is a great sign that the dividend will continue to go one way: up.

Bearing that in mind, let’s dive in and take a closer look at these top five stock picks:

Top Dividend Growth Stocks: Starbucks investorplace.com/wp-content/uploads/2016/09/sbuxmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2016/09/sbuxmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/09/sbuxmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/09/sbuxmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/09/sbuxmsn-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/09/sbuxmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/09/sbuxmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/09/sbuxmsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/09/sbuxmsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Adrianna Calvo via Stock Snap

The creator of the Unicorn Frappuccino, Starbucks Corporation (NASDAQ:SBUX) pays its investors a relatively high dividend yield of 2.11%. At the moment, SBUX is trading ex-dividend until the payout date on Dec. 1, 2017.

This means only investors who have already purchased SBUX shares will receive this 30-cent dividend payout — up 5 cents from the previous payment. Indeed, over the past 10 years, Starbucks displays an encouraging 10-year dividend growth rate of 500%.

Luckily for investors, the stock’s “strong buy” rating suggests that dividends will keep growing. Analysts are optimistic about the growth And now could be a smart time to invest, with shares at $56.8, some ways off the $64.60 seen in June.

Management has just officially reduced guidance with a new long-term EPS growth target of 12%-plus. According to Oppenheimer’s Brian Bittner this was the right move. He says the reduction was widely expected, and the new target sets a more appropriate bar for management.

Wells Fargo’s Bonnie Herzog agrees and recommends buying dips. She says the company’s $15B three-year share repurchase program “signals to the market its commitment to deliver above-industry shareholder returns irrespective of operating headwinds.”

Meanwhile, her $63 price target comes out slightly above the $62.19 average analyst price target. In the past three months, 13 out of 16 analysts have recorded a bullish sentiment on SBUX.

Top Dividend Growth Stock: Lam Research investorplace.com/wp-content/uploads/2017/11/lrcxmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/11/lrcxmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/11/lrcxmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/11/lrcxmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/11/lrcxmsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/11/lrcxmsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/11/lrcxmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/11/lrcxmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/11/lrcxmsn-78×43.jpg 78w,https://investorplace.com/wp-content/uploads/2017/11/lrcxmsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: shutterstock

This top semiconductor stock is one of the best tech stocks out there. In the past year, the stock has more than doubled from just $106 to the current share price of $216. And now Lam Research Corporation (NASDAQ:LRCX) has just announced two fresh capital return actions.

First, a $2.0B 12-18 month share repurchase program has emerged. Secondly, the dividend was hiked 11.0% from $0.45 to $0.50. That’s the second boost since 2014’s initiation with a payout ratio at ~23% of C18E US free cash flow.

Top B.Riley FBR analyst Craig Ellis applauds these two new initiatives. He says they “lend further support to our bullish excess growth thesis.” And ultimately Ellis concludes “we are encouraged by management’s latest shareholder value creation moves and look for upbeat 4Q Semi trends over the next few months to lend further confidence in C18’s Semi Cap fundamentals.”

He reiterated his “buy” rating with a $250 price target on Nov. 14. Considering that the stock is trading at just $216 this suggests sweet upside potential of 15.3% from the current share price.

Note that this five-star analyst seems to know what he is talking about- he is ranked number 1 on TipRanks (out of 4,731 tracked analysts). On LRCX specifically, Ellis boasts a strong track record with 100% success rate and 61.7% average return across his 12 stock ratings.

Overall, Lam Research has a very confident “strong buy” outlook from the Street with 10 “buy” ratings and just 1 hold rating in the past three months.

Top Dividend Growth Stock: UnitedHealth Group UnitedHealth (UNH)investorplace.com/wp-content/uploads/2017/07/unhmsn2-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/07/unhmsn2-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/07/unhmsn2-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/07/unhmsn2-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/07/unhmsn2-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/07/unhmsn2-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/07/unhmsn2-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/07/unhmsn2-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/07/unhmsn2-78×43.jpg 78w,https://investorplace.com/wp-content/uploads/2017/07/unhmsn2-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Shutterstock

This giant health care insurer boasts a very impressive dividend growth rate. UnitedHealth Group Incorporated (NYSE:UNH) has increased its dividend for seven of the last ten years. Back in 2012, the company paid a dividend of $0.2125. Now that number stands at $0.75. We can also look at it from an annual perspective. In 2012 the company paid a total dividend of $0.80. Fast forward to 2017 and the company looks set to pay a dividend of just over $2.87.

The icing on the cake: this stock has received 10 consecutive “buy” ratings from analysts over the last three months. These analysts have an average price target on the stock of $225- 6% upside from the current share price. Note however that the price targets are moving increasingly higher- an encouraging sign of the company’s direction going forward.

Top Cantor Fitzgerald analyst Steven Halper recently wrote an interesting report on UNH. He draws attention to UNH’s fast-growing health services business Optum- which already generated huge revenue in 2016 of $84 billion.

“Optum’s capabilities enhance the operating performance of UHC and represent an important growth vehicle for UNH. UNH has been aggressively deploying capital to build Optum in recent years. Given the combination of strong UHC fundamentals and strong growth at Optum, we believe UNH shares should be a core holding for large-cap portfolio managers” says Halper.

He has a “buy” rating and $225 price target on the stock. It’s also worth mentioning that Halper’s track record that speaks for itself. This five-star analyst boasts a 100% success rate and 26.4% average return across his 23 ratings on UNH stock.

Top Dividend Growth Stock: General Dynamics General Dynamics GD stockinvestorplace.com/wp-content/uploads/2016/06/gdmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2016/06/gdmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/06/gdmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/06/gdmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/06/gdmsn-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/06/gdmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/06/gdmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/06/gdmsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/06/gdmsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Alan Wilson via Flickr (Modified)

This American multinational corporation is one of the world’s largest aerospace and defense contractors based on revenue. From a dividend perspective, General Dynamics Corp (NYSE:GD) offers a yield of 1.68% and a payout of $0.84. This works out at an annualized dividend payment of $3.36. The company has recorded dividend growth for a whopping 25 consecutive years- giving it the nickname “dividend aristocrat.”

Shares in GD are trading slightly lower following mixed Q3 results at the end of October. Indeed, prices are now at $200 from close to $214 last month. For the savvy investor, however, this could represent a buying opportunity. Top Cowen & Co analyst Cai Rumohr has not lost faith in GD.

On the contrary, he says the stock’s “long-term thesis (defense growth; Gulfstream upturn; lots of firepower) remains intact.” And bear in mind that over the past five years this stock has grown fairly consistently from $66 to $200.

Interestingly Rumohr also notes that: “GD trades for a 17% discount to defense big caps LMT, NOC, & RTN on C18 EV/EBITDA, despite peer-high 6-7% revenue growth in 2018-2019 driven by comparable domestic & foreign defense programs.”

His bullish outlook is echoed by the majority of the Street. General Dynamic’s “strong buy” consensus breaks down into five “buy” ratings versus just one “hold” rating in the previous three months.

With an average price target of $226.67, analysts are predicting considerable upside of over 13% from the current share price.

Top Dividend Growth Stock: Visa v stockinvestorplace.com/wp-content/uploads/2017/07/vmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/07/vmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/07/vmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/07/vmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/07/vmsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/07/vmsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/07/vmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/07/vmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/07/vmsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2017/07/vmsn-170×93.jpg 170w” sizes=”(max-width:728px) 100vw, 728px” />Source: Shutterstock

Last but by no means least, we have leading global payments company Visa Inc (NYSE:V). For an investor, Visa is something of a dividend growth dream. The stock boasts a current yield of 0.7%- and a 10-year dividend growth rate of 625%. This breaks down into a very impressive 8 consecutive years of growth. Add to the mix a very low payout ratio and strong earnings potential and you can see why this is a top stock to track right now.

Cantor Fitzgerald’s Joseph Foresi is one of the top 50 analysts on TipRanks. He only recently began to cover V stock, but is already displaying a very bullish sentiment. “We remain attracted to Visa’s dominant position in the global card network market and its strong, recognizable international brand” wrote Foresi on Oct. 26.

Following strong results for the fiscal fourth quarter, Foresi sees promise from “Visa’s opportunity to capitalize on the global conversion of cash into credit, international opportunities, and digital payment tailwinds.”

In total, this “strong buy” stock boasts 16 “buy” ratings in the past three months versus just two “hold” ratings. These analysts have an average price target on the stock of $123.06- with $135 on the high-end. Considering that Visa is now trading at $111.97, this translates into upside potential of 10% from the current share price.

Which stocks are the top 25 analysts recommending right now? Find out here.

TipRanks offers investors the latest insight into eight different sectors by tracking the activity of 4,500 analysts, 5,000 financial bloggers and even 37,000 corporate insiders. As of this writing, Harriet Lefton did not hold a position in any of the aforemen

Best Heal Care Stocks For 2018

Next week’s game plan is all about the Federal Reserve, Jim Cramer told his Mad Money viewers Friday. After today’s strong employment numbers however, Cramer said he’s rooting for an interest rate hike — which would benefit the financials — and a rally isn’t a rally unless the banks are a part of it.

Cramer’s game plan starts on Monday, with earnings from Del Taco Restaurants (TACO)  . Despite strong same-store sales last quarter, Cramer said he’s expecting a struggle this quarter.

Next, on Tuesday, Cramer’s eyes will be on HD Supply (HDS) , the little-known construction supplier with 500,000 customers. This is one investors need to know about, Cramer said.

Wednesday will see the Fed’s latest read on the economy and interest rates, but Cramer will also look to Oracle (ORCL) for a read on software sales, especially overseas.

Best Heal Care Stocks For 2018: Lam Research Corporation(LRCX)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Lam Research (LRCX) has consistently outgrown the overall semiconductor-equipment market due to its high exposure to 3D NAND flash memory.

    Demand for wafer-fabrication equipment is notoriously volatile. However, over the last 90 days, the consensus profit estimate for this year jumped 17%, with 95% of analysts raising their targets.

  • [By Ben Levisohn]

    Lam Research (LRCX) soared to the top of the S&P 500 today after beating earnings forecasts and raising its fourth-quarter guidance.

    Getty Images

    Lam Researchgained 6.9% to $136.17 today, while the S&P 500 declined 0.2% to 2,338.17.

    Credit Suisse analysts Farhan Ahmad and John Pitzer and argues that Lam Research’s “new trough is higher than [its] old peak.” They explain:

    We expect that bears will continue to argue that CY17 is a “Peak” year; however we think that investors are missing that it now costs >2x more to get incremental bit growth than three years ago. It is noteworthy that despite ~$17bn of memory WFE in 2016 both NAND and DRAM markets went from oversupply to undersupply – implying that new trough for memory investments is even higher than old peak (2010 memory peak had WFE of $12.6bn). We view Semi Growth, rising capital intensity, and growing China CapEx as secular multiyear themes, which could continue to provide growth in coming years. In addition, in case of tax reform there could be potential to return >$50 per share to shareholders by 2020…Increase TP to $160 (from $143), based on 12x of CY18 EPS plus net cash adj for taxes.

    Lam Research’s market capitalization rose to $22.2 billion today from $20.8 billion yesterday.

  • [By WWW.THESTREET.COM]

    The same case is made for Action Alerts PLUS holding Alphabet (GOOGL) and for Lam Research (LRCX) and Broadcom (AVGO) and Growth Seeker holding Amazon (AMZN) –and a host of other high-growth companies.

  • [By Dan Caplinger]

    Wednesday was a mixed day for the stock market, as the Dow Jones Industrials dropped by triple digits but other major benchmarks fared much better. Crude oil prices fell nearly $2 per barrel to $50.50, and that hurt energy companies, along with a poor earnings report from technology giant IBM. Yet the broader market held up better, and the Nasdaq Composite actually gained ground. In particular, some good news from a few individual companies helped hold the markets up, and CalAmp (NASDAQ:CAMP), Lithia Motors (NYSE:LAD), and Lam Research (NASDAQ:LRCX) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

Best Heal Care Stocks For 2018: Public Service Enterprise Group Incorporated(PEG)

Advisors’ Opinion:

  • [By Shauna O’Brien]

    Jefferies announced on Tuesday that it has upgraded Public Service Enterprise Group Inc. (PEG).

    The firm has lifted its rating on PEG from “Hold” to “Buy,” and has raised the company’s price target from $36 to $37. This price target suggests a 12% increase from the stock’s current price of $32.42.

    Analyst Paul Fremont commented: “We are upgrading to Buy based on the improving outlook for regulatory approval of the company’s “Energy Strong” capital spending program.

    “Each $1.0 billion of incremental spending will add an estimated $0.10 to PEG’s earnings. We assume that incremental spending is funded by debt and by incremental cash expected from the increasing gas basis differential between the Leidy hub and New Jersey. Our new estimates are considerably higher than consensus in 2014-16.”

    Public Service Enterprise Group shares were mostly flat during pre-market trading Tuesday. The stock is up 6% YTD.

Best Heal Care Stocks For 2018: Extreme Networks Inc.(EXTR)

Advisors’ Opinion:

  • [By Azam Zariff]

    Extreme Networks, Inc. (NASDAQ: EXTR), a communication company, has been on a surge the past year. From the low of $2.32 to high of $8.11 in just over a year, this stock might continue to rise. Besides the strong financials, and positive acquisition news, EXTR current price is testing the high of $8.11 and once the price breaks above $8.11, we can expect the price to surge.